TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 32 USD 4.58% Market Closed
Market Cap: 5.1B USD

Wall Street
Price Targets

TGTX Price Targets Summary
TG Therapeutics Inc

Wall Street analysts forecast TGTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TGTX is 45.17 USD with a low forecast of 13.13 USD and a high forecast of 63 USD.

Lowest
Price Target
13.13 USD
59% Downside
Average
Price Target
45.17 USD
41% Upside
Highest
Price Target
63 USD
97% Upside
TG Therapeutics Inc Competitors:
Price Targets
ENTA
Enanta Pharmaceuticals Inc
37% Upside
VRTX
Vertex Pharmaceuticals Inc
11% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
27% Upside
ACLX
Arcellx Inc
57% Upside
EXAS
Exact Sciences Corp
1% Downside
DVYSR
Devyser Diagnostics AB
53% Upside
FOLD
Amicus Therapeutics Inc
70% Upside
6160
Beigene Ltd
38% Upside

Revenue
Forecast

Revenue Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's revenue for the next 3 years is 52%.

N/A
Past Growth
52%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 123%.

N/A
Past Growth
123%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 153%.

N/A
Past Growth
153%
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TGTX's stock price target?
Price Target
45.17 USD

According to Wall Street analysts, the average 1-year price target for TGTX is 45.17 USD with a low forecast of 13.13 USD and a high forecast of 63 USD.

What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
52%

The compound annual growth rate of TG Therapeutics Inc's revenue for the next 3 years is 52%.

What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
123%

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 3 years is 123%.

What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
153%

The compound annual growth rate of TG Therapeutics Inc's net income for the next 3 years is 153%.

Back to Top